Detalles de la búsqueda
1.
A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumors.
Int J Cancer
; 149(6): 1313-1321, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019700
2.
Evidence for antimicrobial and anticancer activity of pituitary adenylate cyclase-activating polypeptide (PACAP) from North African catfish (Clarias gariepinus): Its potential use as novel therapeutic agent in fish and humans.
Fish Shellfish Immunol
; 86: 559-570, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481557
3.
Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.
J Pept Sci
; 20(11): 850-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25044757
4.
Proteomic Study to Survey the CIGB-552 Antitumor Effect.
Biomed Res Int
; 2015: 124082, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26576414
Resultados
1 -
4
de 4
1
Próxima >
>>